PL2970345T3 - Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA - Google Patents

Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA

Info

Publication number
PL2970345T3
PL2970345T3 PL14721640T PL14721640T PL2970345T3 PL 2970345 T3 PL2970345 T3 PL 2970345T3 PL 14721640 T PL14721640 T PL 14721640T PL 14721640 T PL14721640 T PL 14721640T PL 2970345 T3 PL2970345 T3 PL 2970345T3
Authority
PL
Poland
Prior art keywords
imaging agents
pet imaging
labeled psma
targeted pet
targeted
Prior art date
Application number
PL14721640T
Other languages
English (en)
Inventor
Clifford BERKMAN
Svetlana A. Stekhova
Original Assignee
Cancer Targeted Technology Llc
Washington State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Targeted Technology Llc, Washington State University filed Critical Cancer Targeted Technology Llc
Publication of PL2970345T3 publication Critical patent/PL2970345T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0489Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0402Organic compounds carboxylic acid carriers, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2416Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2454Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14721640T 2013-03-15 2014-03-14 Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA PL2970345T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798108P 2013-03-15 2013-03-15
PCT/US2014/027820 WO2014143736A1 (en) 2013-03-15 2014-03-14 18f-labeled psma-targeted pet imaging agents
EP14721640.2A EP2970345B1 (en) 2013-03-15 2014-03-14 18f-labeled psma-targeted pet imaging agents

Publications (1)

Publication Number Publication Date
PL2970345T3 true PL2970345T3 (pl) 2019-12-31

Family

ID=50639969

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19179758.8T PL3560937T3 (pl) 2013-03-15 2014-03-14 Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA i metody diagnostyczne je wykorzystujące
PL14721640T PL2970345T3 (pl) 2013-03-15 2014-03-14 Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL19179758.8T PL3560937T3 (pl) 2013-03-15 2014-03-14 Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA i metody diagnostyczne je wykorzystujące

Country Status (16)

Country Link
US (2) US11554183B2 (pl)
EP (3) EP2970345B1 (pl)
CN (2) CN105308056B (pl)
AU (2) AU2014228233B2 (pl)
CA (1) CA2903131C (pl)
DK (2) DK2970345T3 (pl)
ES (2) ES2743433T3 (pl)
FI (1) FI3560937T3 (pl)
HR (2) HRP20230109T1 (pl)
HU (2) HUE046194T2 (pl)
LT (2) LT3560937T (pl)
PL (2) PL3560937T3 (pl)
PT (2) PT3560937T (pl)
RS (1) RS64011B1 (pl)
SI (2) SI3560937T1 (pl)
WO (1) WO2014143736A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017027870A1 (en) * 2015-08-13 2017-02-16 The Johns Hopkins University Triazole conjugated ureas, thioureas, carbamates, and "reversed" carbamates for psma-targeted imaging agents and uses thereof
JP7231536B2 (ja) * 2016-08-10 2023-03-01 キャンサー ターゲテッド テクノロジー エルエルシー キレート化されたpsma阻害剤
EP3600024A4 (en) 2017-03-22 2021-01-06 SafeOp Surgical, Inc. MEDICAL SYSTEMS AND METHODS FOR DETECTION OF CHANGES IN ELECTROPHYSIOLOGICALLY AVOID POTENTIALS
WO2018233798A1 (en) 2017-06-20 2018-12-27 ITM Isotopen Technologien München AG NOVEL PSMA BINDING AGENTS AND USE THEREOF
CA3060143A1 (en) 2017-05-24 2018-11-29 Itm Isotopen Technologien Munchen Ag Novel psma-binding agents and uses thereof
WO2020108753A1 (en) 2018-11-28 2020-06-04 ITM Isotopen Technologien München AG Novel tumor antigen binding agents and uses thereof
WO2020224780A1 (en) 2019-05-08 2020-11-12 ITM Isotopen Technologien München AG Para-aminohippuric acid (pah) as a renal protective substance
WO2021046233A1 (en) 2019-09-03 2021-03-11 Cancer Targeted Technology Llc Chelate-containing psma inhibitors
WO2022096103A1 (en) 2020-11-05 2022-05-12 ITM Isotopen Technologien München AG Combination of para-aminohippuric acid (pah) and radiolabeled complexes for treating cancer
WO2022111800A1 (en) 2020-11-25 2022-06-02 Itm Solucin Gmbh Stable formulations for radionuclide complexes
CN117120100A (zh) 2021-04-02 2023-11-24 先进加速器应用公司 前列腺癌的诊断方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2645809C (en) 2006-03-14 2015-05-26 Cancer Targeted Technology Llc Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use
CA2662449A1 (en) * 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18f labeled agents
PL2318366T3 (pl) * 2008-08-01 2017-10-31 Univ Johns Hopkins Środki wiążące PSMA i ich zastosowania
US9328129B2 (en) * 2010-11-12 2016-05-03 Washington State University Peptidomimetic inhibitors of PSMA
CA2839195C (en) * 2011-06-15 2021-10-26 Cancer Targeted Technology Llc Chelated psma inhibitors
CN102757296B (zh) * 2012-04-10 2014-11-19 中国科学院上海应用物理研究所 一种对化合物进行[18f]标记的方法
WO2013173630A1 (en) * 2012-05-16 2013-11-21 Cancer Targeted Technology, Llc Formulation of radiopharmaceuticals containing multiple acidic groups
WO2013173583A1 (en) * 2012-05-16 2013-11-21 Cancer Targeted Technology, Llc Psma inhibitors

Also Published As

Publication number Publication date
EP4180438A1 (en) 2023-05-17
EP2970345A1 (en) 2016-01-20
DK3560937T3 (da) 2023-02-13
PT2970345T (pt) 2019-09-06
PT3560937T (pt) 2023-02-13
US20160030605A1 (en) 2016-02-04
CN105308056B (zh) 2018-03-20
AU2019203610A1 (en) 2019-06-13
FI3560937T3 (fi) 2023-02-28
HRP20191482T1 (hr) 2019-11-15
AU2014228233B2 (en) 2019-02-28
CA2903131C (en) 2021-11-23
WO2014143736A1 (en) 2014-09-18
EP3560937B1 (en) 2022-12-28
US11554183B2 (en) 2023-01-17
CN108558939A (zh) 2018-09-21
PL3560937T3 (pl) 2023-03-27
HRP20230109T1 (hr) 2023-04-28
DK2970345T3 (da) 2019-08-26
EP2970345B1 (en) 2019-06-19
CN108558939B (zh) 2021-08-24
HUE061402T2 (hu) 2023-06-28
ES2937955T3 (es) 2023-04-03
HUE046194T2 (hu) 2020-02-28
US20230144322A1 (en) 2023-05-11
SI2970345T1 (sl) 2019-11-29
LT3560937T (lt) 2023-03-27
LT2970345T (lt) 2019-09-25
EP3560937A1 (en) 2019-10-30
CN105308056A (zh) 2016-02-03
SI3560937T1 (sl) 2023-04-28
AU2019203610B2 (en) 2021-02-04
RS64011B1 (sr) 2023-03-31
AU2014228233A1 (en) 2015-09-17
CA2903131A1 (en) 2014-09-18
ES2743433T3 (es) 2020-02-19

Similar Documents

Publication Publication Date Title
EP2951642A4 (en) OMNISTEREO IMAGING
GB201304149D0 (en) Ultrasound imaging
EP2948047A4 (en) IMAGING BODY STRUCTURES
EP2996149A4 (en) SEMICONDUCTOR IMAGING DEVICE
GB201315248D0 (en) Imaging
PL2970345T3 (pl) Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA
EP2866445A4 (en) IMAGING DEVICE
EP2964658A4 (en) SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS
SG11201507628WA (en) Medical imaging
EP3007435A4 (en) SOLID STATE IMAGING DEVICE
EP2868258A4 (en) IMAGING SYSTEM
EP3041222A4 (en) IMAGING DEVICE
PL3011321T3 (pl) Obrazowanie rentgenowskie z kodowaną przesłoną
EP2944266A4 (en) ULTRASOUND IMAGING DEVICE
PL3038468T3 (pl) Środek bakteriobójczy
EP3087920A4 (en) IMAGING DEVICE FOR ANIMALS
EP2950517A4 (en) IMAGING DEVICE
GB2520243B (en) Image processor
EP2980561A4 (en) IMAGING SYSTEM
GB2530691B (en) Radiation imaging
SG11201601628VA (en) Photoacoustic imaging contrast agent composition
EP2975836A4 (en) IMAGING DEVICE
GB201322068D0 (en) Barrier components for animal stalls
GB201302036D0 (en) Diagnosis
GB201402877D0 (en) Bait Fixing device